Study Summary
This trial compares two electrical stimulation treatments for neuropathic phantom limb pain.
- Pain Management
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
4 Primary · 0 Secondary · Reporting Duration: Baseline, after 10 intervention sessions, about 2 weeks
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
BreEStim
1 of 2
EStim
1 of 2
Experimental Treatment
24 Total Participants · 2 Treatment Groups
Primary Treatment: BreEStim 240 · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 75 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Does this clinical investigation accept participants who are aged 65 or more?
"As per the outlined parameters for inclusion, individuals aged 18 or above but no older than 75 can take part in this study." - Anonymous Online Contributor
How many individuals are engaged in this research endeavor?
"Verified. Clinicaltrials.gov provides evidence that recruitment for this medical research has been underway since April 2nd 2021, and was last modified on May 21st of the same year. The experiment seeks to enlist 24 patients from a single site." - Anonymous Online Contributor
Is enrollment still open for this research endeavor?
"Based on the listings available through clinicaltrials.gov, this study is still recruiting participants. It was originally posted on April 2nd 2021 and the listing has been recently updated as of May 21st 2021." - Anonymous Online Contributor
Am I eligible to take part in this experimental research?
"To be eligible for this medical trial, patients must fulfill the following criteria: ages 18 to 75; currently suffering from [chronic pain](https://www.withpower.com/clinical-trials/chronic-pain) (>3 months); have phantom limb pain (PLP) after amputation of one limb, upper or lower; and remain stable on their current oral pain medications for two weeks." - Anonymous Online Contributor